Health Care · Pharmaceutical Preparations · OTC · CIK 1205922 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.83Day −29.86%Mkt cap $2M1Y −0.3%Off 52W high −44.8%Vol (1Y) 270.3%
Daily closing price, split-adjusted to the current basis; 2.9y shown of 1,992 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.1% of sh out |
| Days to cover2.7d |
| Next report (est.)2026-10-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Sales (TTM)$601,000 |
| Earnings (TTM)-$18.6M |
| Net margin−3100.5% |
| Sales growth 3Y−12.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−23.4% |
| 1Y−0.3% |
| 3Y−98.6% |
| 5Y−99.8% |
| Since incept. (ann.)−63.2% |
Total return through 2026-07-28 · series begins 2018-08-09. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)270.3% |
| Ann. volatility (3Y)211.8% |
| Sharpe (1Y)1.25 |
| Sharpe (3Y)0.37 |
| Max drawdown (1Y)−66.0% |
| Max drawdown (3Y)−99.5% |
| Beta (3Y vs SPY)1.98 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for VCNX.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2024-12-31 | 2025-04-15 | — | — | $213,000 | — |
| 2024-09-30 | 2024-11-14 | −$2.83 | — | $52,000 | +160.0% |
| 2024-06-30 | 2024-08-14 | −$3.10 | — | $232,000 | — |
| 2024-03-31 | 2024-05-15 | −$2.94 | — | $104,000 | −81.1% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
